Cogent Biosciences Inc (NASDAQ:COGT) traded at $6.50 at close of the session on Tuesday, April 30, made a downward move of -3.13% on its previous day’s price.
Looking at the stock we see that its previous close was $6.71 . In terms of its 52-week price range, COGT has a high of $13.50 and a low of $3.67. The company’s stock has lost about -5.80% over that past 30 days.
Cogent Biosciences Inc has a market cap of $621.47 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.52, with the EPS growth for the year raised at -$2 for 2024 and -$1.99 for next year. These figures represent 17.40% and 0.50% growth in EPS for the two years respectively.
On the other hand, looking at the outlook for the COGT stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -1.99% off its SMA20 and -5.57% from its 50-day simple moving average. The RSI (14) is pointing at 48.58 while the volatility over the past week is 7.27% and jumps to 6.56% over the past one month. The beta value is 1.57, while the average true range (ATR) is currently pointing at 0.47.
Coming back to Cogent Biosciences Inc (NASDAQ:COGT), we note that the average 3-month trading volume was 2.14 million. Current shares outstanding are 86.12 million.
The insiders hold 11.55% of the company’s shares while institutions hold 80.52%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 10.54% up in year-to-date price movement.
